These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2542382)

  • 1. Characterization of concentration- and use-dependent effects of quinidine from conduction delay and declining conduction velocity in canine Purkinje fibers.
    Packer DL; Grant AO; Strauss HC; Starmer CF
    J Clin Invest; 1989 Jun; 83(6):2109-19. PubMed ID: 2542382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct quantification of apparent binding indices from quinidine-induced in vivo conduction delay in canine myocardium.
    Haugland FN; Johnson SB; Packer DL
    J Clin Invest; 1994 Apr; 93(4):1798-811. PubMed ID: 8163679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
    Valois M; Sasyniuk BI
    Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of quinidine on the transmembrane potentials of young and adult canine cardiac Purkinje fibers.
    Morikawa Y; Rosen MR
    J Pharmacol Exp Ther; 1986 Mar; 236(3):832-7. PubMed ID: 3950873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of halothane and quinidine on canine Purkinje fibers: evidence for a synergistic interaction.
    Gallagher JD; Gessman LJ; Moura P; Kerns D
    Anesthesiology; 1986 Sep; 65(3):278-85. PubMed ID: 3752573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of the electrophysiological effects of the antiarrhythmic agent quinidine in canine purkinje fibers.
    Wang CM; Parker CH
    Life Sci; 1980 Aug; 27(8):663-70. PubMed ID: 7412495
    [No Abstract]   [Full Text] [Related]  

  • 8. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide.
    Nattel S; Bailey JC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.
    Davidenko JM; Cohen L; Goodrow R; Antzelevitch C
    Circulation; 1989 Mar; 79(3):674-86. PubMed ID: 2917391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.
    Roden DM; Hoffman BF
    Circ Res; 1985 Jun; 56(6):857-67. PubMed ID: 4006095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-dependent electrophysiological effects of quinidine and lidocaine on canine cardiac purkinje fibers.
    Nattel S; Elharrar V; Zipes DP; Bailey JC
    Circ Res; 1981 Jan; 48(1):55-61. PubMed ID: 7438346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of quinidine on transmembrane action potentials of normal and infarcted canine Purkinje fibers.
    Montero M; Beyer T; Schmitt C; Kübler W; Brachmann J
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):304-10. PubMed ID: 1381023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs.
    Pallandi RT; Campbell TJ
    Cardiovasc Res; 1988 Mar; 22(3):171-8. PubMed ID: 3167941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of disopyramide and quinidine on action potentials of canine ventricular myocardium and Purkinje fibers after myocardial infarction].
    Gao TL; Brachmann J; Senges J
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):238-42. PubMed ID: 2959020
    [No Abstract]   [Full Text] [Related]  

  • 16. Interval-dependent effects of lidocaine on conduction in canine cardiac Purkinje fibers: experimental observations and theoretical analysis.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):275-81. PubMed ID: 3572789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purkinje and ventricular activation sequences of canine papillary muscle. Effects of quinidine and calcium on the Purkinje-ventricular conduction delay.
    Veenstra RD; Joyner RW; Rawling DA
    Circ Res; 1984 May; 54(5):500-15. PubMed ID: 6722999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency- and voltage-dependent effects of disopyramide in canine Purkinje fibers.
    Flemming MA; Sasyniuk BI
    Can J Physiol Pharmacol; 1989 Jul; 67(7):710-21. PubMed ID: 2766102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle.
    Iida M; Kodama I; Toyama J
    Cardiovasc Res; 1996 Apr; 31(4):640-50. PubMed ID: 8689657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage dependence of beta-adrenergic modulation of conduction in the canine Purkinje fiber.
    Munger TM; Johnson SB; Packer DL
    Circ Res; 1994 Sep; 75(3):511-9. PubMed ID: 8062424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.